Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (WBA) has rescheduled its fiscal year 2025 first quarter earnings announcement from January 9 to January 10, 2024. The change is due to the closure of the Securities and Exchange Commission and U.S. stock markets on January 9 in observance of a national day of mourning for former President Jimmy Carter.
The company will release its Q1 results at 7 a.m. ET on January 10, followed by a one-hour conference call with management at 8:30 a.m. ET. The earnings call will be simulcast through WBA's investor relations website, with a replay available for 12 months after the call.
This story has been deleted by the news provider.
CaringBridge and Walgreens (WBA) announced a two-day donation matching campaign on December 17-18, where Walgreens will match donations up to $50,000. This initiative extends their existing partnership through CaringBridge.TheGiftCardShop.com, where CaringBridge receives 3% of every Walgreens gift card purchase value to support caregivers of individuals with health challenges.
The platform, powered by InComm Payments, enables people to send gift cards to family caregivers, providing practical support for health supplies, prescriptions, and daily necessities. The gift cards are available through 'Ways to Help' on CaringBridge pages and their dedicated gift card shop website.
Walgreens has launched its inaugural Clinical Trials Patient Advisory Board, consisting of 10 patient experts who will serve 2-year terms. The board will collaborate with the Walgreens Clinical Trials team to enhance representation in clinical research, particularly focusing on historically excluded communities.
Since launching in June 2022, the Clinical Trials team has reached over 7 million patients for potential recruitment into sponsor-led trials. This initiative addresses significant challenges in clinical research, as only 5% of the U.S. population participates in clinical trials, and nearly 80% of trials fail to meet enrollment goals.
Walgreens reveals that 47% of Americans have missed holiday events due to illness, with nearly one-third worried about it happening again. The company's survey shows 82% of respondents prioritize health and well-being, with 40% planning preventative measures like vaccinations. Walgreens is responding with a holiday campaign focused on health, offering vaccinations nationwide and various wellness products.
The trend is particularly strong among younger generations, with 75% of Gen Z and 70% of Millennials more likely to make health-related changes this holiday season. To support customers, Walgreens is providing convenient access to health products, staying open during major holidays, and offering services like Same Day Refill, 30-minute in-store Pickup, and 1-hour Delivery.
Walgreens Boots Alliance (WBA) has announced it will release its fiscal year 2025 first quarter financial results on Thursday, January 9 at 7 a.m. ET. The announcement will be followed by a one-hour conference call with management at 8:30 a.m. ET. The call will be available through a simulcast on the company's investor relations website, with a replay accessible for 12 months afterward.
Walgreens Boots Alliance (WBA) announces a proposed settlement for a stockholder derivative action in the U.S. District Court for the District of Delaware. The lawsuit, filed by James Clem on behalf of Walgreens, addresses alleged breaches of fiduciary duties related to statements about a proposed Rite Aid merger. The settlement includes corporate governance reforms to be maintained for 5 years, focusing on board attendance, director training, audit committee responsibilities, and whistleblower controls. The agreement includes $750,000 in attorney fees and potential $2,500 service award for the plaintiff. A settlement hearing is scheduled for January 23, 2025.
Walgreens (WBA) has expanded its partnership with the CDC to offer no-cost rapid COVID-19 and flu testing to military veterans at stores nationwide. The service provides combination tests with results in 30 minutes or less. Veterans can schedule appointments online or walk in, requiring only self-attestation of veteran status and either symptoms or recent COVID-19 exposure. The program includes follow-up care referrals to VA Health Connect and pharmacist consultation for positive cases. Uninsured patients can also access free testing through this CDC program. Since partnering with CDC in 2020, Walgreens has administered over 37 million COVID-19 tests.
Walgreens has launched its 2024-2025 Flu Index, an interactive online tool tracking weekly flu activity through prescription data from its pharmacies nationwide. The index, running for 11 years, shows southern states typically experience earlier and more intense flu peaks. Despite current low activity levels, a seasonal spike is anticipated. Rick Gates, chief pharmacy officer, emphasizes the importance of protection against flu, COVID-19, and RSV before the holiday season. The company offers various vaccination options, including walk-ins and scheduled appointments, with a 20% discount promotion for myWalgreens members on purchases of $20 or more after vaccination.
Walgreens is offering a special 20% discount to veterans, active-duty military personnel, and their families from November 8 through November 11, 2024. The discount applies to regular-priced eligible store items at all Walgreens and Duane Reade locations nationwide.
Through the free myWalgreens loyalty program, members can earn additional benefits including 1% Walgreens Cash rewards storewide and 5% on Walgreens branded products. The discount requires proof of service and myWalgreens membership, which can be obtained at checkout or online. Stores will maintain regular business hours on Veterans Day, with 24-hour pharmacies remaining open and select non-24-hour pharmacies operating with modified hours.